Allianz Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Allianz Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-484,234	Closed	-$2.5M	–	2870
2019 Q2	$2.5M	Buy	484,234 +188,451	+64%	+$847K	﹤0.01%	1801
2019 Q1	$1.06M	Buy	+295,783	New	+$1.28M	﹤0.01%	2069

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Allianz Asset Management's PETX Position: Q3 2019 in Review

Allianz Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 484,234 shares — an estimated $2.5M sold.

Allianz Asset Management first reported a position in PETX in Q1 2019 and held it in 2 quarters. The position peaked at $2.5M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Allianz Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Allianz Asset Management sold 484,234 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $2.5M.
Allianz Asset Management first reported a position in Aratana Therapeutics, Inc. in Q1 2019 and held it in 2 quarters.
Allianz Asset Management's Aratana Therapeutics, Inc. position peaked at $2.5M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Allianz Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.